NCT05442073

Brief Summary

Esophageal manometry was used as surrogate of pleural pressure to titrate positive end-expiratory pressure (PEEP) in ARDS patients. However, Absolute values of esophageal pressure (Pes) could be affected by the PEEP setting. In moderate to severe ARDS patients, the end-expiratory Pes changed differently with PEEP adjustment. and the esophageal phenotypes could be divided into type I and type II. with Type I (ΔPes≥30%ΔPEEP)and Type II(ΔPes\<30%ΔPEEP).

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
18

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Mar 2022

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 1, 2022

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 31, 2022

Completed
28 days until next milestone

First Submitted

Initial submission to the registry

June 28, 2022

Completed
1 day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 29, 2022

Completed
2 days until next milestone

First Posted

Study publicly available on registry

July 1, 2022

Completed
Last Updated

July 1, 2022

Status Verified

June 1, 2022

Enrollment Period

3 months

First QC Date

June 28, 2022

Last Update Submit

June 28, 2022

Conditions

Outcome Measures

Primary Outcomes (1)

  • the changes of esophageal pressure during the PEEP titration

    March 1st to May 31st, 2022

Study Arms (2)

Type I: ΔPes≥30%ΔPEEP

Other: PEEP adjustment

Type II: ΔPes<30%ΔPEEP

Other: PEEP adjustment

Interventions

adjusting PEEP about 3-5cmH2O (increase or decrease)

Type I: ΔPes≥30%ΔPEEPType II: ΔPes<30%ΔPEEP

Eligibility Criteria

Age18 Years - 90 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Adult patients all the moderate to severe ARDS with P/F\<200 no contraindication to esophageal catheter

You may qualify if:

  • \- aged over 18 all the moderate to severe ARDS patients invasive mechanical ventilation

You may not qualify if:

  • aged\<18 contraindication to esophageal catheter

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Peking Union Medical College Hospital

Beijing, Beijing Municipality, 100730, China

Location

MeSH Terms

Conditions

Respiratory Distress SyndromePositive-Pressure Respiration, Intrinsic

Condition Hierarchy (Ancestors)

Lung DiseasesRespiratory Tract DiseasesRespiration DisordersRespiratory Insufficiency

Study Officials

  • Shuyang Zhang, MD

    Peking Union Medical College Hospital

    STUDY CHAIR

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
PROSPECTIVE
Target Duration
28 Days
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 28, 2022

First Posted

July 1, 2022

Study Start

March 1, 2022

Primary Completion

May 31, 2022

Study Completion

June 29, 2022

Last Updated

July 1, 2022

Record last verified: 2022-06

Data Sharing

IPD Sharing
Will not share

Locations